Chertow GM - Search Results

1

Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease.

Chertow GM, Vart P, Jongs N, Toto RD, Gorriz JL, Hou FF, McMurray JJV, Correa-Rotter R, Rossing P, Sjöström CD, Stefánsson BV, Langkilde AM, Wheeler DC, Heerspink HJL; DAPA-CKD Trial Committees and Investigators. Chertow GM, et al. J Am Soc Nephrol. 2021 Sep;32(9):2352-2361. doi: 10.1681/ASN.2021020167. Epub 2021 Jul 16. J Am Soc Nephrol. 2021. PMID: 34272327 Free PMC article. Clinical Trial.

2

The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.

De Boer IH, Gorodetskaya I, Young B, Hsu CY, Chertow GM. De Boer IH, et al. Among authors: chertow gm. J Am Soc Nephrol. 2002 Nov;13(11):2762-9. doi: 10.1097/01.asn.0000034202.91413.eb. J Am Soc Nephrol. 2002. PMID: 12397047

3

The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.

Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD. Chertow GM, et al. Am J Nephrol. 2003 Sep-Oct;23(5):307-14. doi: 10.1159/000072822. Epub 2003 Aug 12. Am J Nephrol. 2003. PMID: 12915774 Free article. Clinical Trial.

4

Cognitive impairment in chronic kidney disease.

Kurella M, Chertow GM, Luan J, Yaffe K. Kurella M, et al. Among authors: chertow gm. J Am Geriatr Soc. 2004 Nov;52(11):1863-9. doi: 10.1111/j.1532-5415.2004.52508.x. J Am Geriatr Soc. 2004. PMID: 15507063

5

Suicide in the United States end-stage renal disease program.

Kurella M, Kimmel PL, Young BS, Chertow GM. Kurella M, et al. Among authors: chertow gm. J Am Soc Nephrol. 2005 Mar;16(3):774-81. doi: 10.1681/ASN.2004070550. Epub 2005 Jan 19. J Am Soc Nephrol. 2005. PMID: 15659561

6

Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study.

Kurella M, Chertow GM, Fried LF, Cummings SR, Harris T, Simonsick E, Satterfield S, Ayonayon H, Yaffe K. Kurella M, et al. Among authors: chertow gm. J Am Soc Nephrol. 2005 Jul;16(7):2127-33. doi: 10.1681/ASN.2005010005. Epub 2005 May 11. J Am Soc Nephrol. 2005. PMID: 15888561

7

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.

Kurella M, Lo JC, Chertow GM. Kurella M, et al. Among authors: chertow gm. J Am Soc Nephrol. 2005 Jul;16(7):2134-40. doi: 10.1681/ASN.2005010106. Epub 2005 May 18. J Am Soc Nephrol. 2005. PMID: 15901764

8

Angiotensin receptor blockade and arterial compliance in chronic kidney disease: a pilot study.

Garg JP, Ellis R, Elliott WJ, Hasabou N, Chua D, Chertow GM, Bakris GL. Garg JP, et al. Among authors: chertow gm. Am J Nephrol. 2005 Jul-Aug;25(4):393-9. doi: 10.1159/000087211. Epub 2005 Jul 25. Am J Nephrol. 2005. PMID: 16088080 Clinical Trial.

9

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Chertow GM, et al. J Am Soc Nephrol. 2005 Nov;16(11):3365-70. doi: 10.1681/ASN.2004090740. Epub 2005 Sep 21. J Am Soc Nephrol. 2005. PMID: 16177006

10

Differential mortality and transplantation rates among Asians and Pacific Islanders with ESRD.

Hall YN, Sugihara JG, Go AS, Chertow GM. Hall YN, et al. Among authors: chertow gm. J Am Soc Nephrol. 2005 Dec;16(12):3711-20. doi: 10.1681/ASN.2005060580. Epub 2005 Oct 19. J Am Soc Nephrol. 2005. PMID: 16236803

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

814 results

Search Page